The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
245 episodes — Page 5 of 5
965: Does the bispectral index correlate well to commonly used sedation scales?
Show notes at pharmacyjoe.com/episode965. In this episode, I’ll discuss whether the bispectral index (BIS) correlates well to commonly used sedation scales.
964: The SQuID Protocol for DKA Treatment – Sounds cool but how well does it work?
Show notes at pharmacyjoe.com/episode964. In this episode, I’ll discuss subcutaneous insulin therapy for patients with low to moderate severity DKA.
963: What Works Best for Toxin-Related Status Epilepticus?
Show notes at pharmacyjoe.com/episode963. In this episode, I’ll discuss what works best for toxin-related status epilepticus.
Episode 962: What Antibiotics Are Best At Toxin Inhibition?
Show notes at pharmacyjoe.com/episode962. In this episode, I’ll discuss the antibiotics that inhibit bacterial toxin production.
961: Is that gabapentin just temporary?
Show notes at pharmacyjoe.com/episode961. In this episode, I’ll discuss the continuation of newly prescribed gabapentin for acute pain management after hospital discharge.
960: A titrated morphine algorithm that worked well in ED patients
Show notes at pharmacyjoe.com/episode960. In this episode, I’ll discuss a titrated morphine algorithm that worked well in ED patients.
959: Is there a benefit from switching to dexmedetomidine when sedation is started with midazolam?
Show notes at pharmacyjoe.com/episode959. In this episode, I’ll discuss whether there is a benefit from switching to dexmedetomidine when sedation is started with midazolam.
958: Sepsis and AFib heart rate differences with phenylephrine vs norepinephrine
Show notes at pharmacyjoe.com/episode958. In this episode, I’ll discuss differences in heart rate in patients with sepsis and AFib between phenylephrine and norepineprhine.
957: Not every professional critical care society is high on ketamine for analgosedation
Show notes at pharmacyjoe.com/episode957. In this episode, I’ll discuss a recent practice guideline on ketamine use for analgosedation in critically ill patients.
956: Beware of vancomycin treatment failure with old CVVHDF dosing regimens
Show notes at pharmacyjoe.com/episode956. In this episode, I’ll discuss the possibility of vancomycin treatment failure with old CVVHDF dosing regimens.
955: Has Everyone Gotten the Mechanism of Phenobarbital in Alcohol Withdrawal Wrong?
Show notes at pharmacyjoe.com/episode955. In this episode, I’ll discuss the use of phenobarbital in severe alcohol withdrawal.
954: Why should an ICU pharmacist be concerned about recognizing and treating malignant hyperthermia?
Show notes at pharmacyjoe.com/episode954. In this episode, I’ll discuss the ICU pharmacist’s role in recognizing and treating malignant hyperthermia.
953: Sugammadex Versus Neostigmine Side Effects
Show notes at pharmacyjoe.com/episode953. In this episode, I’ll discuss an article about the side effects of sugammadex vs neostigmine.
952: What is the optimal urine output cutoff point to identify acute kidney injury in critically Ill patients?
Show notes at pharmacyjoe.com/episode952. In this episode, I’ll discuss the optimal urine output cutoff point to identify acute kidney injury in critically Ill patients.
951: Getting the depth of sedation correct in the ED might reduce mortality rates by half
Show notes at pharmacyjoe.com/episode951. In this episode, I’ll discuss how getting the depth of sedation correct in the ED might reduce mortality rates by half.
950: Is clevidipine no faster than nicardipine to reach goal BP in a hypertensive crisis?
Show notes at pharmacyjoe.com/episode950. In this episode, I’ll discuss clevidipine vs nicardipine and the time to reach goal BP in a hypertensive crisis.
949: How well does subcutaneous insulin work for DKA treatment?
Show notes at pharmacyjoe.com/episode949. In this episode, I’ll discuss subcutaneous insulin for the treatment of diabetic ketoacidosis (DKA).
948: Does reducing the induction agent dose lessen the chance of postintubation hypotension?
Show notes at pharmacyjoe.com/episode948. In this episode, I’ll discuss postintubation hypotension following rapid sequence intubation with full vs. reduced-dose induction agent.
947: If anaphylaxis to sugammadex is so rare, why make such a big deal about it?
Show notes at pharmacyjoe.com/episode947. In this episode, I’ll discuss anaphylaxis to sugammadex.
946: Animal data suggest calcium does not stabilize the cardiac membrane in hyperkalemia
Show notes at pharmacyjoe.com/episode946. In this episode, I’ll discuss the effects of calcium during treatment of hyperkalemia.
945: How does the use of dopamine for shock affect mortality rates?
Show notes at pharmacyjoe.com/episode945. In this episode, I’ll discuss how the use of dopamine for shock affects mortality rates.
944: Stress Ulcer Prophylaxis – A Guideline Update 25 Years in the Making
Show notes at pharmacyjoe.com/episode944. In this episode, I’ll discuss the new SCCM and ASHP joint guidelines on stress ulcer prophylaxis in critically ill patients.
943: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients
Show notes at pharmacyjoe.com/episode943. In this episode, I’ll discuss the risk factors associated with the development of venous thromboembolism in ICU patients.
942: Mannitol administration for elevated intracranial pressure
Show notes at pharmacyjoe.com/episode942. In this episode, I’ll discuss the administration of mannitol for elevated intracranial pressure.
941: Can non-verbal ICU pain scales indicate the severity of pain?
Show notes at pharmacyjoe.com/episode941. In this episode, I’ll discuss whether non-verbal ICU pain scales can indicate the severity of pain.
940: Does Tranexamic Acid Have a Role In Aneurysmal Subarachnoid Hemorrhage?
Show notes at pharmacyjoe.com/episode940. In this episode, I’ll discuss whether tranexamic acid has a role in the treatment of aneurysmal subarachnoid hemorrhage.
939: Lipid Rescue Dosing for LAST vs Enteral Drug Toxicity
Show notes at pharmacyjoe.com/episode939. In this episode, I’ll discuss the dosing of lipid rescue therapy for LAST vs enteral drug toxicity.
938: Can you predict the chance of cardiovascular event from bupropion overdose?
Show notes at pharmacyjoe.com/episode938. In this episode, I’ll discuss the chance of cardiovascular toxicity from bupropion overdose.
937: Is your micro lab hiding susceptibility data from you?
Show notes at pharmacyjoe.com/episode937. In this episode, I’ll discuss the suppression of antimicrobial susceptibility results.
936: Why does ketamine for RSI sometimes cause post-induction hemodynamic instability?
Show notes at pharmacyjoe.com/episode936. In this episode, I’ll discuss why ketamine can sometimes cause post-induction hemodynamic instability when it is used for rapid sequence intubation.
935: What vasopressor is best to use in traumatic brain injury?
Show notes at pharmacyjoe.com/episode935. In this episode, I’ll discuss an article about which vasopressor is best in early traumatic brain injury patients.
934: Fondaparinux in critically ill patients with severe renal dysfunction
Show notes at pharmacyjoe.com/episode934. In this episode, I’ll discuss an article about using fondaparinux in critically ill patients with severe renal dysfunction.
933: Can tenecteplase be used for acute ischemic stroke beyond 4.5 hours from time last know well?
Show notes at pharmacyjoe.com/episode933. In this episode, I’ll discuss tenecteplase for stroke from 4.5 to 24 hours after the time last know well.
932: Major Developments in Stress Ulcer Prophylaxis Evidence
Show notes at pharmacyjoe.com/episode932. In this episode, I’ll discuss recent articles regarding stress ulcer prophylaxis.
931: Non-dextrose purge solution for patients with an Impella that require a PET scan
Show notes at pharmacyjoe.com/episode931. In this episode, I’ll discuss an alternative to a dextrose-based purge solution for patients with an Impella ventricular assist device that also need a PET scan.
930: How does obesity affect SC and IM medication administration?
Show notes at pharmacyjoe.com/episode930. In this episode, I’ll discuss how obesity affects SC and IM medication administration.
929: What is the incidence of torsades from low-dose ondansetron in peri-operative patients?
Show notes at pharmacyjoe.com/episode929. In this episode, I’ll discuss the incidence of torsades from low-dose ondansetron in peri-operative patients.
928: What is the best vasopressor to use in post-resuscitation shock?
Show notes at pharmacyjoe.com/episode928. In this episode, I’ll discuss what vasopressor to use in post-resuscitation shock.
927: Tetanus immune globulin
Show notes at pharmacyjoe.com/episode927. In this episode, I’ll discuss the use of tetanus immune globulin.
926: How well does nebulized ketamine work for pain compared with IV?
Show notes at pharmacyjoe.com/episode926. In this episode, I’ll discuss an article about nebulized vs IV ketamine for analgesia in the ED.
925: What are the risk factors for serious and general opioid-related adverse drug events?
Show notes at pharmacyjoe.com/episode925. In this episode, I’ll discuss an article about risk factors for serious and general opioid-related adverse drug events.
924: Does Antibiotic Exposure Intensity Affect the Risk of Clostridioides Difficile Infection?
Show notes at pharmacyjoe.com/episode924. In this episode, I’ll discuss if antibiotic exposure intensity affects the risk of clostridioides difficile infection.